Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.
about
Methotrexate for treating rheumatoid arthritisFolic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritisMethotrexate in rheumatoid arthritis: a quarter century of developmentAnti-inflammatory mechanisms of methotrexate in rheumatoid arthritisLong-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month updateLiver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalysesComparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.A clinical approach to the use of methotrexate for sarcoidosisMethotrexate induced pancytopenia.Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.Methotrexate for rheumatoid arthritis.Drug therapy of ulcerative colitisWill pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?Molecular mechanism of methotrexate action in inflammation.Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatmentA case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiencyC677T (RS1801133 ) MTHFR gene polymorphism frequency in a colombian population.Rheumatoid arthritis: an overview of new and emerging therapies.Recommendations for the use of methotrexate in juvenile idiopathic arthritis.Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.Methotrexate in asthma.Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.Current immunotherapy in rheumatoid arthritis.Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials.Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story.Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.Methotrexate and rheumatoid arthritis.Methotrexate in rheumatoid arthritis: an update.Evaluative laboratory testing. Assessing tests that assess disease activity.Advances and issues in the pharmacotherapy of rheumatoid arthritis.The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis.Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritisMethotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation.
P2860
Q24194047-3A61A3B2-C7C9-4FFE-AC86-8F2FD0430C00Q24202950-3954E3F3-FF9F-4C7D-8975-E1DA04EBFEC5Q24597346-016D79A9-67DE-4453-9AE9-6AE3A0C5107FQ24674760-2962C5D0-2C9B-4DB5-93D7-272EF1E53C6EQ28324515-8044713E-544A-433A-A1D0-BAA83EDBE71FQ28335980-C97CFEAC-ED17-4E3B-8F63-15FE27BB0814Q29542806-13CB0ADB-73E2-468B-896A-3B4E7FE05FAEQ33362595-57E15AA1-A765-4CD7-B198-0FDDB049BF61Q33449383-3CA5E510-D1A2-489C-A056-18309837525FQ33496750-9069DB50-0833-45D3-809C-1BED41D4ED1CQ33691304-93B21629-8005-41DB-932A-6927CBB069A2Q33804885-E5EC6863-D98A-49C5-8189-98057FD1F2DDQ33908108-CB3902DB-CA3A-4257-A75E-6B1C1DA26A17Q33908140-35186FD9-16CB-4FA9-ABC4-449E1057B1EFQ34403155-1A7AFA08-4141-4DB5-8A77-70A938383EC7Q35024962-F23DE5A2-0AA6-4526-B18D-7635D6CE1C27Q35501813-147E9B8A-ACCD-4E06-B9DB-F754BB99B301Q35638735-37144E48-4509-4ED7-A282-A2672E22CC25Q35938335-8BEC61AC-C598-4F26-B54E-39200ECD13B4Q35954562-0416A8E5-55AD-48EC-811D-BFA051EBC0EAQ36160669-106A2594-093B-4098-ACFE-703B793EE80EQ36677248-00A36C8D-E910-4964-A668-9E697C536BD3Q36683921-CE46C595-A837-478E-AFF3-F9093164BA2CQ36723705-01CF60EF-7107-4234-B6A3-7AE2240B2A24Q36753260-9B3FFBB2-4313-4314-BD55-CB048DE90180Q36787761-18271901-BDBF-4273-A1B6-BCDD3DA3B37FQ37464238-A6CE5C0B-DE87-4B55-BEAF-E53342BB753AQ37498849-6ACD7CB4-6267-4CAB-869C-DF7D90026A20Q38133655-54D7A456-37B6-445F-B775-4B70EA014A9BQ38140867-39312CD0-98CF-4B62-B244-289BD379A570Q38214382-10126A2A-51A3-4B14-AD88-9B91DEED5FD5Q38862981-15EF4646-069D-46BC-9A3D-A0C9FFB0F426Q38939820-AE60B3B2-ADCF-488E-A7C4-EBC2678892C1Q39651892-03B86F22-2071-429C-95B2-910DFFD67608Q39746666-313007E4-297C-42A1-98D5-E761813F8B63Q40375304-78B9825F-4591-476D-88DB-D7ADFD72BB73Q40434105-2E7ABC10-A79C-4A2E-92D0-E89B010AE038Q41200879-8B38C0A5-37A1-4C46-9B7E-655A89DF8271Q41208644-B5D97A3C-A13D-4852-A5C6-76378A1A679EQ41215001-C71822DE-AF27-4796-9882-E1E881621405
P2860
Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@en
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@nl
type
label
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@en
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@nl
prefLabel
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@en
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@nl
P2093
P1476
Weekly pulse methotrexate in r ...... andomized, double-blind study.
@en
P2093
P304
P356
10.7326/0003-4819-103-4-489
P407
P577
1985-10-01T00:00:00Z